Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Venous Thromboembolism
94%
Thromboprophylaxis
62%
Deep Vein Thrombosis
52%
Low Molecular Weight Heparin
44%
Fondaparinux
44%
Enoxaparin
33%
Orthopedic Surgery
32%
Major Orthopedic Surgery
31%
Pulmonary Embolism
27%
Venous Thromboembolism Prophylaxis
27%
Venous Thromboembolism Prevention
25%
Extended Duration
21%
Unfractionated Heparin
20%
Surgical Patients
18%
Total Hip Arthroplasty
17%
Aspirin
14%
Hospital Discharge
14%
Thrombosis
14%
Large Joints
13%
Joint Surgery
13%
Orthopaedic Patients
13%
Abdominal Surgery
11%
Knee Arthroscopy
11%
Orthopedics
11%
Treatment Dose
11%
High Risk
11%
Extended Thromboprophylaxis
11%
Bleeding Rate
11%
Major Bleeding
11%
Bleeding
10%
Pentasaccharide
10%
Venous Thromboembolic Events
9%
Placebo
9%
Vitamin K Antagonists
9%
Pharmacologic
8%
Thromboembolism
8%
Quality Issues
8%
Stratification Tools
8%
Diagnostic Factor
8%
Blind Comparison
8%
Intermittent Pneumatic Compression
8%
Randomized Double-blind
8%
Novel Oral Anticoagulants
8%
Bridging Therapy
8%
Medical Patients
8%
Day Surgery
8%
High-risk Surgical Patients
8%
Ligamentoplasty
8%
Fondaparinux Sodium
8%
Needlestick Injuries
8%
Medicine and Dentistry
Venous Thromboembolism
100%
Deep Vein Thrombosis
57%
Thromboprophylaxis
51%
Orthopedic Surgery
41%
Low Molecular Weight Heparin
30%
Pulmonary Embolism
24%
Heparin
24%
Orthopedics
21%
Thromboembolism
18%
Antithrombotic
18%
Health Care Cost
16%
Acetylsalicylic Acid
14%
Operation on Joint
13%
Knee Arthroscopy
11%
Thrombosis
11%
Systematic Review
9%
Meta-Analysis
9%
Bleeding
9%
Rehabilitation Center
8%
Ambulatory Surgery
8%
Ligament Surgery
8%
Safety Syringe
8%
Total Hip Arthroplasty
8%
Thrombosis Prevention
8%
Surgical Risk
8%
Direct Oral Anticoagulant
8%
Major Bleeding
8%
Needlestick Injury
8%
Awareness
6%
Wound
5%
Physical Medicine and Rehabilitation
5%
Patient Population
5%
Warfarin
5%
Surgical Technique
5%
Fondaparinux
5%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
98%
Deep Vein Thrombosis
41%
Fondaparinux
39%
Enoxaparin
35%
Low Molecular Weight Heparin
33%
Heparin
30%
Bleeding
18%
Lung Embolism
16%
Anticoagulant Agent
12%
Acetylsalicylic Acid
11%
Pentasaccharide
10%
Placebo
10%
Thromboembolism
9%
Pharmacokinetic
8%
Morbid Obesity
8%
Rivaroxaban
8%
Wound
8%
Needlestick Injury
8%
Randomized Controlled Trial
8%
Antithrombin
8%
Warfarin
5%
Clinical Trial
5%
